In an interaction with Maulik Patel, CMD, Epigral Ltd
In an interaction with Maulik Patel, CMD, Epigral Ltd

In an interaction with Maulik Patel, CMD, Epigral Ltd

We have witnessed improvement quarter on quarter, even when the overall chemical industry was under pressure, says Maulik Patel, CMD, Epigral Ltd.

Siddharth Mane Article rating: 4.0

We have witnessed improvement quarter on quarter, even when the overall chemical industry was under pressure, says Maulik Patel, CMD, Epigral Ltd.

DSIJ MINDSHARE

Mkt Commentary11-Mar, 2025

Mindshare11-Mar, 2025

Quarterly Results11-Mar, 2025

Penny Stocks11-Mar, 2025

Mindshare11-Mar, 2025

Knowledge

Fundamental9-Mar, 2025

Technical8-Mar, 2025

Knowledge8-Mar, 2025

Understanding the Retail Debt Market

Understanding the Retail Debt Market

Debt securities are financial instruments like bonds or loans issued by companies or governments to raise...
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR